Adjuvant External Beam Radiotherapy ± Brachytherapy in Endometrial Cancer: A Retrospective Study from Faculty of Medicine, Chiang Mai University


Purpose: To report the retrospective study of external beam radiotherapy (EBRT) ± intravaginal brachytherapy (IVBT) as adjuvant treatment for endometrial cancer. Materials and Methods: From 2001-2009, 152 patients received complete surgical staging for endometrial carcinoma and were designed by a multidisciplinary team to receive EBRT ± IVBT. The treatment results and late toxicities were evaluated and recorded. Results: At the median follow-up time of 43 months, the disease-free survival, metastasis-free survival and overall survival rates were 96.9%, 96.9% and 96.9%, respectively. Stage and age showed the statistical significance with the p-value of less than 0.001. From five to ten percent of patients developed Grades 1-2 late gastrointestinal and genitourinary toxicities, respectively. Conclusion: The using of adjuvant EBRT ± IVBT for endometrial carcinoma yielded treatment results and acceptable toxicities.

Share and Cite:

Tharavichitkul, E. , Prasitwattanaseree, S. , Traisathit, P. , Thipmate, C. , Chakrabandhu, S. , Klunklin, P. , Onchan, W. , Galalae, R. and Chitapanarux, I. (2015) Adjuvant External Beam Radiotherapy ± Brachytherapy in Endometrial Cancer: A Retrospective Study from Faculty of Medicine, Chiang Mai University. Journal of Cancer Therapy, 6, 115-121. doi: 10.4236/jct.2015.62012.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Tangjitgamol, S., Manusirivithaya, S., Srijaipracharoen, S., Khunnarong, J., Tanvanich, S., Katanyu, K., et al. (2010) Endometrial Cancer in Thai Women: Clinico-Pathological Presentation and Survival. Asian Pacific Journal of Cancer Prevention, 11, 1267-1272.
[2] Keys, H.M., Roberts, J.A., Brunetto, V.L., Zaino, R.J., Spirtos, N.M., Bloss, J.D., et al. (2004) A Phase III Trial of Surgery with or without Adjunctive External Pelvic Radiation Therapy in Intermediate Risk Endometrial Adenocarcinoma: a Gynecologic Oncology Group Study. Gynecologic Oncology, 92, 744-751.
[3] Creutzberg, C.L., van Putten, W.L., Koper, P.C., Lybeert, M.L., Jobsen, J.J., Wárlám-Rodenhuis, C.C., et al. (2000) Surgery and Postoperative Radio-Therapy versus Surgery Alone for Patients with Stage-1 Endometrial Carcinoma; Multicenter Randomized Trial. Lancet, 355, 1404-1411.
[4] ASTEC/EN.5 Study Group, Blake, P., Swart, A.M., Orton, J., Kitchener, H., Whelan, T., Lukka, H., et al. (2009) Adjuvant External Beam Radiotherapy in the Treatment of Endometrial Cancer (MRC ASTEC and NCIC-CTG EN.5 Randomised Trials): Pooled Trial Results, Systematic Review, and Meta-Analysis. Lancet, 373, 137-146.
[5] Aalders, J., Abeler, V., Kolstad, P. and Onsrud, M. (1980) Postoperative External Irradiation and Prognostic Parameters in Stage I Endometrial Carcinoma: Clinical and Histopathologic Study of 540 Patients. Obstetrics & Gynecology, 56, 419-427.
[6] Miller, A.B., Hoogstraten, B., Staquet, M. and Winkler, A. (1981) Reporting Results of Cancer Treatment. Cancer, 47, 207-214.<207::AID-CNCR2820470134>3.0.CO;2-6
[7] Cox, J.D., Stetz, J. and Pajak, T.F. (1995) Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). International Journal of Radiation Oncology Biology Physics, 31, 1341-1346.
[8] Kaplan, E.L. and Meier, P. (1958) Non-Parametric Estimation from Incomplete Observations. Journal of the American Statistical Association, 53, 457-481.
[9] Mantel, N. (1966) Evaluation of Survival Data and Two New Rank Order Statistics Arising in Its Consideration. Cancer Chemotherapy Reports, 50, 163-170.
[10] Cox, D.R. (1972) Regression Models and Life Tables. Journal of the Royal Statistical Society: Series B, 34, 187-220.
[11] Nori, D., Merimsky, O., Batata, M. and Caputo, T. (1994) Postoperative High Dose-Rate Intravaginal Brachytherapy Combined with External Irradiation for Early Stage Endometrial Cancer: A Long Term Follow-Up. International Journal of Radiation Oncology*Biology*Physics, 30, 831-837.
[12] Algan, O., Tabesh, T., Hanlon, A., Hogan, W.M., Boente, M. and Lanciano, R.M. (1996) Improved Outcome in Patients Treated with Postoperative Radiation Therapy for Pathologic Stage I/II Endometrial Cancer. International Journal of Radiation Oncology*Biology*Physics, 35, 925-933.
[13] Nout, R.A., Smit, V.T., Putter, H., Jürgenliemk-Schulz, I.M., Jobsen, J.J., Lutgens, L.C., et al. (2010) Vaginal Brachytherapy versus Pelvic External Beam Radiotherapy for Patients with Endometrial Cancer of High-Intermediate Risk (PORTEC-2): An Open-Label, Non-Inferiority, Randomised Trial. Lancet, 375, 816-823.
[14] Tharavichitkul, E., Prasitwattanseree, S., Thipmate, C., Chakrabandhu, S., Klunklin, P., Onchan, W., et al. (2015) Treatment Results of Adjuvant Brachytherapy as Monotherapy in Endometrial Cancer: A Retrospective Study from Faculty of Medicine, Chiang Mai University. Journal of Cancer Therapy, 6, 34-39.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.